Advertisement

Topics

Compass Therapeutics Company Profile

19:40 EST 14th November 2018 | BioPortfolio

Compass Therapeutics currently has over 15 antibody, antibody combination and bispecific programs advancing through preclinical development, targeting multiple pathways of significance for the immune system. The company’s offices, labs and vivarium are based in Kendall Square in Cambridge, Mass. Compass currently has approximately 70 full-time employees.


News Articles [781 Associated News Articles listed on BioPortfolio]

Compass Therapeutics Closes on Series A Financing Totaling $132 Million

Compass Therapeutics closed on the final $49 million of its $132 million Series A financing. The funds raised will be used to push their lead product, CTX-471 into the clinic as well as to identify tw...

Compass Therapeutics closes $132mm Series A round

Compass Therapeutics (antibody therapies for cancer) raised a total of $132mm through a multi-tranche Series A round that began in 2015. OrbiMed Advisors led and was joined by F-Prime Capital, Cowen H...

Venture Funding Deals: Alector, Ascentage, Gossamer And Compass Lead Summer Rounds

Compass raises $132m in Series A as it moves from screening to the clinic, and start-up HotSpot Therapeutics comes out...    

Compass’ range

Compass’ multispecific antibody screening and engineering platform allows for efficient library building.

FDA grants breakthrough status to COMPASS' depression therapy

The FDA granted breakthrough therapy designation to COMPASS Pathways' psilocybin, which is indicated for treatment-resistant  -More- 

FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that it has been named by Fierce...

FDA approves Compass' study for treatment-resistant depression drug

The FDA approved a Phase IIb clinical trial for Compass' psilocybin therapy for patients with treatment-resistant depression. -More- 

Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-Generation ...

Initial programs to focus on immuno-oncology, inflammation and autoimmune disorders Read more...

PubMed Articles [492 Associated PubMed Articles listed on BioPortfolio]

A comparison between the Compass fundus perimeter and the Humphrey Field Analyzer.

To evaluate relative diagnostic precision and test retest variability of two devices, the Compass (CMP, CenterVue, Italy) fundus perimeter and the Humphrey Field Analyzer (HFA, Zeiss, Dublin), in dete...

Mll-COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts.

Expression of Runx2/p57 is a hallmark of the osteoblast-lineage identity. Although several regulators that control the expression of Runx2/p57 during osteoblast-lineage commitment have been identified...

Sequential Multiple Assignment Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS).

Patient management is not based on a single decision. Rather it is dynamic, based on a sequence of decisions with therapeutic adjustments made over time. Adjustments are personalized, tailored to indi...

Randomized Control Trial of COMPASS for Improving Transition Outcomes of Students with Autism Spectrum Disorder.

The postsecondary outcomes of individuals with autism spectrum disorder (ASD) are significantly worse than peers with other disabilities. One problem is the lack of empirically-supported transition pl...

COMPASS Results For Clinical Practice Opinion of the Expert Council of November 22, 2017.

Clinical Trials [181 Associated Clinical Trials listed on BioPortfolio]

Compass Course: Efficacy Study

The Compass Course is an 8-session progressive structure that was developed based on theoretical and scientific evidence from psychology and occupational therapy. The goal of the intervent...

A Study to Assess Long-Term Safety of the Transcend CyPass Micro-Stent in Patients Completing the COMPASS Trial

This is an observational study involving patients who completed the COMPASS Trial, in which the Transcend Medical CyPass Micro-Stent was evaluated through 2 years postoperatively . In the ...

Compass Hinge Stabilization of Knee Dislocations: A Randomized Trial

The purpose of this project is to evaluate the effect of the Compass™ Universal Hinge external fixator on the outcome of patients following acute dislocation of the knee

COMPASS-HF Extension Phase

The purpose of the Extension Phase of the COMPASS-HF study is to continue to observe the safety of the Chronicle® Implantable Hemodynamic Monitor (IHM) system and provide study doctors co...

The Effectiveness of the Mobile-based Youth COMPASS Program to Promote Adolescent Well-being and Life-control

The aim of this randomized control trial is to examine effectiveness of individually tailored web- and mobile-based Acceptance- and Commitment Therapy interventions to promote adolescents'...

Companies [1297 Associated Companies listed on BioPortfolio]

Compass Therapeutics

Compass Therapeutics currently has over 15 antibody, antibody combination and bispecific programs advancing through preclinical development, targeting multiple pathways of signifi...

Compass Surgical Partners

Compass Surgical Partners specializes in the management, acquisition and development of ambulatory surgery centers (ASCs) through application of operational discipline and ...

Compass Professional Health Services

Compass Professional Health Services is the champion for simpler, smarter healthcare. At a time when companies are shifting more costs to employees through higher deductibles and ...

Compass Health Brands

Compass Health is Northwest Washington’s behavioral healthcare leader. The organization integrates behavioral health and medical care services to support clients and communit...

Compass Group

Based in Charlotte NC, Compass Group North America is the leading foodservice and support services company with $9.2 billion in revenues in 2009. With 386,000 associates worldwide, its parent company,...

More Information about "Compass Therapeutics" on BioPortfolio

We have published hundreds of Compass Therapeutics news stories on BioPortfolio along with dozens of Compass Therapeutics Clinical Trials and PubMed Articles about Compass Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Compass Therapeutics Companies in our database. You can also find out about relevant Compass Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record